Upcoming Status Page Transition


On April 26, 2026, starting at 11:00 AM ET, products will transition from this status page to a single consolidated status page. The transition is expected to take 1–2 hours.


All products will be available at https://status.optum.com, except Pharmacy products, which will transition at a later date. Thank you for your patience as we improve service visibility.

Updated Inhalation Meds Announcement

Scheduled for Mar 17, 17:45 - 17:55 EDT

Scheduled

Optum Insight has completed claims testing in collaboration with the Provider Outreach & Education (POE) team to validate payment accuracy and claim reopening outcomes with the new dispense fee modifier. Based on this review, please disregard our former instruction for non-Recovery clients to take related denials to re-openings. We are actively addressing inhalation dispense fee denials for both Recovery & non-Recovery clients which occurred before inhalation claims were placed on hold Feb. 20, 2026. No action is required from providers currently.

System enhancements resulting from this collaborative testing are scheduled for completion by mid-April. At that time, claims that were previously on hold will be released for processing. We appreciate your continued partnership.
Posted Mar 17, 2026 - 17:43 EDT
This scheduled maintenance affects: Pharmacy Solutions (MedRx).